PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune ...
PRINCETON, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (PDSB) (PDS Biotech or Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results